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Ureteric buddingEmbryonic kidney development begins with the outgrowth of the ureteric bud (UB) from the Wolfﬁan duct
(WD) into the adjacent metanephric mesenchyme (MM). Both a GDNF-dependent and GDNF-independent
(Maeshima et al., 2007) pathway have been identiﬁed. In vivo and in vitro, the GDNF-dependent pathway is
inhibited by BMPs, one of the factors invoked to explain the limitation of UB formation in the unbudded regions
of theWD surrounding the UB. However, the exact mechanism remains unknown. Here a previously described
in vitro system thatmodels UB budding from theWDwas utilized to study this process. Because Protein kinase
A (PKA) activation has been shown to prevent migration, morphogenesis and tubulogenesis of epithelial cells
(Santos et al., 1993), its activity in budded and non-budded portions of the GDNF-induced WD was analyzed.
The level of PKA activitywas 15-fold higher in the unbudded portions of theWD compared to budded portions,
suggesting that PKA activity plays a key role in controlling the site of UB emergence. Using well-characterized
PKA agonists and antagonists, we demonstrated that at various levels of the PKA-signaling hierarchy, PKA
regulates UB outgrowth from the WD by suppressing budding events. This process appeared to be PKA-2
isoform speciﬁc, andmediated by changes in the duct rather than the surroundingmesenchyme. In addition, it
was not due to changes in either the sorting of junctional proteins, cell death, or cell proliferation. Furthermore,
the suppressive effect of cAMP on budding did not appear to be mediated by spread to adjacent cells via gap
junctions. Conversely, antagonism of PKA activity stimulated UB outgrowth from theWD and resulted in both
an increase in the number of buds per unit length of WD as well as a larger surface area per bud. Using
microarrays, analysis of gene expression in GDNF-treated WDs in which the PKA pathway had been activated
revealed a nearly 14-fold decrease in Ret, a receptor for GDNF. A smaller decrease in GFRα1. a co-receptor for
GDNF, was also observed. Using Ret-null WDs, we were able to demonstrate that PKA regulated
GDNF-dependent budding but not GDNF-independent pathway for WD budding. We also found that BMP2
was higher in unbudded regions of the GDNF-stimulated WD. Treatment of isolated WDs with BMP2
suppressed budding and resulted in a 3-fold increase in PKA activity. The data suggests that the suppression of
budding by BMPs and possibly other factors in non-budded zones of the WD may be regulated in part by
increased PKA activity, probably partially through downregulation of Ret/GFRα1 coreceptor expression.dicine, Cellular and Molecular
an Drive, La Jolla, CA 92093-
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The initiation of embryonic kidney development begins when the
Wolfﬁan duct (WD), a paired mesonephric organ in mammalian
embryos, interacts with its surrounding metanephric mesenchyme
(MM), resulting in a localized epithelial outgrowth of the WD known
as a ureteric bud (UB). The development of the UB is critical to the
development of the renal collecting duct system as well as reciprocal
induction of the MM to form the nephron (Costantini, 2006; Pohlet al., 2000; Shah et al., 2009). Disruptions to this process, and the
resulting renal malformations that are a major cause of kidney failure
in the pediatric population, have prompted research on the genetic
framework that governs this early stage of kidney development
(Kerecuk et al., 2008).
Normal buddingof theUB fromtheWD is dependent onglial cell line
derived neurotrophic factor (GDNF) interacting with its co-receptors
Ret and GFRα1. This process has been analyzed in considerable detail in
vitro (Choi et al., 2009; Maeshima et al., 2006; Sainio et al., 1997) and in
vivo (Chi et al., 2009; Costantini and Shakya, 2006; Shakya et al., 2005;
Towers et al., 1998). Recently, a GDNF-independent (“bypass”)
pathway, dependent on FGF signaling and inhibition of the suppressive
effect of Sprouty or a TGFβ superfamily member (i.e. activin), has been
identiﬁed and is supported by in vitro and in vivo data (Maeshima et al.,
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important when GDNF–Ret signaling is inactive or disrupted. In the
normal GDNF-dependent pathway, the regulation of budding events
appears to be dependent on the balance of stimulation by GDNF and
FGFs on the onehand, and suppressionbybonemorphogenetic proteins
(BMPs) and possibly other TGFβ superfamily members on the other
(Bush et al., 2004; Hartwig et al., 2008).
Suppression of budding in the non-budded region is crucial to
ensure that supernumerary UBs do not form from the WD. Members
of the TGFβ superfamily have been considered as candidate molecules
in this process due to their inhibitory effects on UB branching (Bush
et al., 2004; Piscione et al., 1997; Rogers et al., 1993; Sakurai and
Nigam, 1997; Santos and Nigam, 1993), an idea supported by genetic
data. For example, knockout of Grem1, a BMP antagonist, results in
renal agenesis (Michos et al., 2004) while knockout of BMP4 leads to
duplication of the collecting system in mice (Miyazaki et al., 2000).
Despite the evidence supporting the role of these molecules in
suppression of budding of theWD, the signalingmechanisms involved
in this process remain poorly understood. It has previously been
demonstrated that protein kinase A (PKA) is activated by BMP2 in
IMCD cells which are ultimately of WD origin (Barros et al., 1995;
Gupta et al., 1999); in cultured renal epithelial cells, PKA activation
blocks epithelial cell migration andmorphogenesis (Klebe et al., 1995;
Rosen et al., 1990; Santos et al., 1993). Suchmorphogenetic events are
required for UB formation (Chi et al., 2009; Nigam, 2003); thus, we
sought to evaluate the possibility that localized suppression of
budding in the WD is mediated by PKA. Our results support this
view and suggest that BMPs and/or other TGFβ superfamily members
might inhibit budding by local activation of PKA, in part by markedly
downregulating Ret.
Materials and methods
Reagents
Recombinant GDNF, ﬁbroblast growth factor (FGF)-1, FGF-7,
follistatin, and bone morphogenetic protein (BMP)-2 were purchased
from R&D systems (Minneapolis, MN). Fetal bovine serum (FBS) was
purchased from Biowhittaker (Walkersville, MD). DMEM/F12, 3-
isobutyl-1-methylxanthine (IBMX), 8-bromoadenosine-3', 5'-cyclic
monophosphate, sodium salt (8-Br-cAMP), PKI (14-22), myristoy-
lated inhibitor (PKAi), KT5720, 4',6-diamidino-2-phenyl-indole,
dihyrochloride (DAPI), anti-ZO-1 antibody, anti-connexin-26 anti-
body, and Alexa Fluor 594 and 488 IgG secondary ﬂuorescent
antibodies were purchased from Invitrogen (Carlsbad, CA). 8-
piperidinoadenosine-3',5'-cyclic monophosphate (8-PIP-cAMP),
N6-Mono-t.-butylcarbamoyladenosine-3',5'-cyclic monophosphate
(6-MBC-cAMP), 8-N-hexylaminoadenosine-3',5'-cyclic monopho-
sphate (8-HA-cAMPS), 5,6-dichloro-1-β-D-ribofuranosyl benzimid-
azole-3',5'-cyclic monophosphorothioate (Sp-5,6-DCl-cBIMPS), 8-(4-
chlorophenylthio)-2'-O-methyladenosine 3',5'-cyclic monophosphate
(8-CPT-2'-O-Me-cAMP), 8-(4-chlorophenylthio)adenosine-3',5'-cy-
clic monophosphorothioate Rp-isomer (Rp-8-CPT-cAMPS), and for-
skolin where purchased from Axxora (San Diego, CA). 4-
[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone (rolipram),
and adenosine 3′,5′-cyclic monophosphate, N6,O2′-dibutyryl (db-
cAMP) were purchased from EMD Biosciences (San Diego, CA).
18β-glycyrrhetinic acid were purchased from Sigma-Aldrich
(St. Louis, MO). Antibody to E-cadherin and PKA-RII regulatory
subunit was purchased from BD Biosciences (San Jose, CA).
Isolation and culture of the Wolfﬁan duct
Timed pregnant Sprague–Dawley rats (Harlan, Indianapolis, IN)
were bred to day 13 of gestation (where day 0 was the day of
appearance of the vaginal plug). For the Ret-knockout experiments,Ret-heterozygous mice were graciously provided by Dr. Frank
Costantini (Columbia University, NY) (Schuchardt et al., 1996) and
timed pregnantmicewere intercross bred to day 11.5 of gestation. The
embryos were dissected free of surrounding placental tissues. TheWD
as well as the adjacent mesonephros (the associated mesonephric
tissues including gonadal ridge) were identiﬁed under stereomicro-
scopy. Using mechanical dissection with ﬁne forceps, the WDs were
isolated and stripped away from the bulk of the adjacentmesonephros
under traction, resulting in a 75- to 100-μM sheath of mesenchymal
cells that remained attached to the isolatedWD.Optionally, this sheath
was removed under further mechanical dissection with ﬁne forceps
and residual mesenchymal cells were brushed off under friction with
collected gonadal ridge tissue extracted from the embryo. WDs were
placed on top of Transwell ﬁlters (0.4 μm pore size) (Costar, Cam-
bridge, MA) that were situated within respective wells of a 12-well
tissue culture dish. In the subgroup ofWDs inwhich themesenchymal
cells were removed, these WDs were instead suspended in a 1:1
Matrigel:DMEM/F12 extracellular matrix gel situated on top of
Transwell ﬁlters. The isolated control tissues were cultured at 37 °C
and 5% CO2/100% humidity in DMEM/F12 supplemented with 10%
FBS, 125 ng/mL of FGF1, and 125 ng/mL of GDNF. The additions of
FGF1 and GDNF were required to induce UB outgrowth from theWDs,
without which budding was nonexistent even in cultured sheathed
WDs. This culture media was further supplemented by speciﬁc
inhibitors and stimulators of the cAMP-dependent PKA pathway at
concentrations noted. In a subset of experiments, the adjacent
mesonephros was left intact with the isolated WD, allowing for the
induction ofUB outgrowthwithGDNF alone. AGDNF/Ret independent
control in Ret-knockout mice experiments was served by replacing
FGF1 and GDNF with FGF7 (125 ng/mL) and follistatin (500 ng/mL).
Brightﬁeld images of the cultures were taken at intervals using a Spot
RT Slider digital camera attached to a Nikon Eclipse TE300microscope.
Cultures were then ﬁxed with 4% paraformaldehyde (PFA) prior to
immunohistological analysis.
Quantitative measurement of PKA enzyme activity and WD lysate
collection
WDs were collected under control and experimental media
conditions at d2 (n=20 per condition). Optionally, UB outgrowths
were dissected frombuddedWDs. Collectionswerewashed three times
with PBS chilled to 4 °C. The supernatant was discarded, and the pellets
of tissue were suspended in Biosource's Omnia Cell Lysate (Camarillo,
CA) with the addition of Sigma's Protease Inhibitor Cocktail and
Phosphatase Inhibitor Cocktail 1 (St. Louis, MO), each to a dilution
ratio of 1:100 of cocktail:lysate. Each collection was further lysed for
30 min on a rotator and then centrifuged at 13,000 rpm for 20 min at
4 °C. To allow for normalization of relative enzyme activity, quantitative
assayof the amountWDcells in eachcollectionwasperformedwithBio-
Rad's DC Protein Assay (Hercules, CA) with protein concentration
measured on a BMG FLUOstar microplate reader (Durham, NC) at an
absorbance λ=650 nm standardized to a concurrently run dilution
series of Bio-Rad's lyophilized bovine serum albumin Protein Assay
Standard II (Hercules, CA). Relative ﬂuorescence units (RFU) over time
were measured every 2 min over a 20-min period for each collection
with the Biosource Omnia Lysate Assay for PKA (Camarillo, CA) per kit
protocol on the BMG FLUOstarmicroplate reader through λex=365 nm
and λem=486 nm ﬁlters purchased from Edmund Optics (Barrington,
NJ). The calibration curve for PKA enzyme activity was derived for the
provided PKA Sox-modiﬁed phosphorylated peptide control versus PKA
Sox-modiﬁed peptide substrate by measuring RFU over a graded series
of prepared peptide concentrations (0.5 μM to 10 μM). PKA enzyme
activity for each WD collection was calculated from slope of the linear
least-squares ﬁt of the RFU/second divided by the slope of the
phosphopeptide standard calibration curve to correct for the decrease
in ﬂuorescence intensity resulting from substrate consumption.
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The WD cultures were ﬁxed in 4% PFA for 30 min, washed in Tris-
buffered saline containing 0.3% Triton-X (TBST) for 5 min three times
and then incubated in 1.5% BSA-TBST for 20 min at 4 °C. The cultures
were then reacted with primary antibody in TBST at 4 °C overnight.
After 1 h of washing with TBST at 4 °C, the cultures were re-incubated
with secondary antibody in TBST at 4 °C overnight. After washing in
TBST for a ﬁnal hour, the cultures were mounted in ProLong® Gold
antifade reagent (Invitrogen, Carlsbad, CA) and visualized with a
Nikon D-Eclipse C1 camera attached to a Nikon D-Eclipse 80i confocal
microscope.
Detection of cell proliferation and apoptosis
Cultured WDs were labeled with 100 μM bromodeoxyuridine
(BrdU) for 3 h. After extensive washing with PBS, the WDs were ﬁxed
with 4% PFA. Cell proliferation was analyzed by BrdU labeling using a
Cell proliferation kit (Amersham, Piscataway, NJ). For identiﬁcation of
nuclei with DNA strand breaks at the cellular level, the terminal
deoxynucleotidyl transferase-mediated dUTP-nick-end-labeling
(TUNEL) staining was performed using a DeadEndTM Fluorometric
TUNEL System (Promega, Madison, WI) per manufacturer's instruc-
tions. Quantiﬁcation of BrdU-positive or TUNEL-positive cells was
performed by counting positive nuclei in total cells (DAPI-positive
nuclei) from selected ﬁelds using a Spot RT Slider digital camera
attached to a Nikon Eclipse 80i epiﬂuorescent microscope. Values are
expressed as the mean±S.E. (n=20).
Microarray and pathway analysis
RNAwas extracted from culturedWolfﬁan ducts in the presence or
absence of protein kinase A stimulation using Applied Biosystem's
RNAqueous-Micro RNA Puriﬁcation kit (Foster City, CA). Three
biological replicates, each with a minimum RNA amount of 2 μg and
concentration of 200 ng/μL, were submitted to the University of
California San Diego Genechip Microarray Core (La Jolla, CA) for RNA
gene expression proﬁling on Affymetrix's Genechip rat genome 230
2.0 array (Santa Clara, CA). Results were analyzed with Agilent
Technologies' Genespring GX software version 7.3.1 (Santa Clara, CA).
Statistically signiﬁcant gene expression was determined by one-way
analysis of variance. Subsets of annotated genes were curated with
Gene Ontology (Ashburner et al., 2000). Molecular pathway analyses
were performed by transferring the gene lists and comparative
experimental data generated in Genespring GX and script transferred
to Ingenuity System's Ingenuity Pathways Analysis version 7.1
(Redwood City, CA) for further analyses.
Knockout mice
To identify heterozygosity and homozygosity for Ret gene
knockout in each embryo, genomic DNA was isolated and ampliﬁed
from each embryonic tail with Sigma-Aldrich's REDExtract-N-Amp
tissue PCR kit (St. Louis, MO). Sets of primerswere used for themurine
Ret gene (forward 5'-TGGGAGAAGGCGAGTTTGGAAA-3' and reverse
5'-TTCAGGAACACTGGCTACCATG-3', 221 base-pair product) and for
the inserted neomycin (Neo) resistant gene (forward 5'-AGAGGC-
TATTCGGCTATGACTG-3' and reverse 5'-CCTGATCGACAA-
GACCGGCTTC-3', 416 base-pair product). The PCR was performed at
94 °C, 30 s; 65 °C, 1 min; 72 °C, 1 min for forty cycles and the
ampliﬁcation products were then separated on a 2% agarose gel.
Real-time quantitative PCR
RNA was extracted from both cultured and uncultured Wolfﬁan
ducts using Applied Biosystem's RNAqueous-Micro RNA Puriﬁcationkit (Foster City, CA), and further ampliﬁed into cDNA with the
SuperScript III system from Invitrogen (Carlsbad, CA) with ~100 ng of
RNA per reaction. Primers for selected genes were generated using
Primer Express 3.0 software from Applied Biosystems (Foster City,
CA). Sets of primers were used for the Ret gene (forward 5'-
TGCTGCCTGTCACCCTGAA-3' and reverse 5'-CACGCAAACTTTCC-
CAATCTG-3'), GFRα1 gene (forward 5'-TGAGATCCCCACACACGTTTT-
3' and reverse 5'-CCGACACATTGGATTTCAGCTT-3’), and GAPDH
reference gene for normalization (forward 5'-TGCATCCTGCACCAC-
CAA-3' and reverse 5'-TCCACGATGCCAAAGTTGTC-3'). Quantitative
PCR was performed using Syber Green/Rox from Invitrogen (Carls-
bad, CA), with the Applied Biosystems Fast Real-Time PCR 7500
(Foster City, CA). Cycle thresholds (Ct) values were normalized to
GAPDH using the formula 2(GAPDH-sample). Samples were analyzed as
three biological replicates and three technical replicates; signiﬁcant
fold changes were determined using Student's t-test.
In-situ hybridization
The Ret plasmid was cloned from a 603 base pair fragment of the
mouse Ret gene into a pCR iiTopo plasmid. Digoxygenin labeled RNA
probes were synthesized for both sense and antisense strands. WDs
were cultured until desired timepoint and then ﬁxed ﬁrst in cold
methanol, then overnight in 4% formaldehyde in PBS. The WDs were
then incubated at room temperature in 0.1% Tween 20 in PBS (PBT)
for 10 min, 10 μg/mL proteinase K in PBT for 15 min, washed in PBT
three times for a total of 15 min, and then post-ﬁxed for 40 min in 4%
formaldehyde in PBT. TheWDs were then incubated for 2 h at 65 °C in
a solution of 50% deionized formamide, 25% 20× SSC, 2% Roche
blocking powder, 0.1% Tween 20, 0.5% CHAPS, 1 mg/mL yeast tRNA,
0.5 m EDTA and 0.05% heparin. Sense or antisense probe was
preheated to 80 °C for 3 min, and then added at 250 ng/mL and left
overnight at 60 °C. Samples were then washed in a post-hybridization
solution consisting of 50% formamide, 25% 20× SSC, 0.1% Tween 20,
and 0.5% CHAPS twice for a total of 20 min, then in 75% post-
hybridization solution (diluted in 2× SSC) for 10 min, then 50% for
10 min, and then 25% for 10 min. The WDs were then washed a ﬁnal
time in 2× SSC with 0.1% CHAPS twice for a total of 60 min, and then
0.2× SSC with 0.1% CHAPS for another 60 min. The WDs were then
blocked in TBST with 10% sheep serum, incubated overnight in 1:200
alkaline phosphatase-conjugated anti-DIG (Roche/Genentech, San
Francisco, CA), and developed the next day in NBT/BCIP solution.
Sense controls were performed to support antisense experiments, and
were negative.
Animal care
The care and use of animals described in this study conform to the
procedures of the laboratory's Animal Protocol approved by the
Animal Subjects Program of the University of California, San Diego.
Results
15-fold increase in PKA activity in non-budded versus budded WD
The signaling events preventing supernumerary UB formation in
non-budded portions of the tubular epithelialWD are unknown. It has
previously been demonstrated that processes essential to UB
formation, such as epithelial cell migration and tubulogenesis, are
inhibited by activation of PKA (Rosen et al., 1990; Santos et al., 1993),
and that this could be a BMP2-mediated process (Gupta et al., 1999).
This led us to hypothesize that the balance of PKA activity between the
budded and unbudded regions of the WDmay be part of the signaling
mechanism that allows budding in one portion of the WD while
suppressing it in the rest of the duct. Potentially, this could be related
to the mechanism behind BMP suppression of budding. To evaluate
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outgrowth, the budded portions were separated from the remaining
unbudded portion of the isolatedWD (Fig. 1A) and the relative level of
PKA (normalized for tissue quantity) was measured (Fig. 1B).
Importantly, PKA activitywas 15-fold higher in the unbudded sections
of the WD in comparison to the isolated buds (pb0.01), which
suggests that regulation of PKA activity in the ductal cells plays a key
role in the inhibition of UB outgrowth. Given that a role for PKA has
not been explored in WD budding, we sought to determine whether
PKA activity can affect the budding of the Wolfﬁan duct by analyzing
three experimental conditions: a control group of WDs isolated with a
sheath of surrounding mesenchymal cells (WDctrl; FGF1 and GDNF
alone); these WDs cultured in the presence of increased PKA activity
(WDPKA+; supplemented with dibutyryl-cAMP 200 μM), or cultured
in the presence of inhibitors of PKA (WDPKA-; supplemented with
PKAi(14–22) 10 μM).
Protein kinase A inhibits ureteric bud outgrowth from the WD via a
non-Epac pathway
To determine the effect of PKA on the emergence of the UB from the
WD, it was important to determine the effect ofmodifying each step of
the PKA-signaling pathway. This was accomplished by exposing the
WD to well-characterized PKA activators and inhibitors acting at each
level of the pathway (Fig. 2A–C). Upstream activation of PKA either by
stimulation of adenylate cyclase (with forskolin 10–20 μM), or
inhibition of phosphodiesterase (with IBMX 20–200 μM, or rolipram
50–100 μM), resulted in the complete inhibition of UB outgrowth from
the WD. Direct activation of PKA with membrane-permeable cAMP
analogues (dibutyryl-cAMP 100–400 μM, or 8-Br-cAMP 100–400 μM)
yielded similar arrest of WD budding. A measured increase in PKA
activity was conﬁrmed in the cultured WD tissue (71% over control;
pb0.05). When these WDPKA+ were then transferred at 2 days ofFig. 1. Protein kinase A activity in the budded and unbudded portions of the cultured Wol
(A) Dashed box highlights a representative ureteric bud outgrowth separated from the un
concentration assay,was calculated from the slope of the linear least-squaresﬁt of the PKA ass
The difference in PKA enzyme activity between budded and unbudded portions of theWDw
blue—DAPI. Scale bar=100 μm.culture to control media lacking dibutyryl-cAMP and cultured for an
additional 3 days, UB outgrowth from these WDs was observed albeit
with a decreased number of buds per equivalent length of WD
compared to WDctrl (2.1±0.8 buds per millimeter of WD versus
4.1±1.3 buds per millimeter of WD respectively). To determine
whether this cAMP-mediated inhibition of buddingmight be the result
of increased exchange protein activated by cAMP (Epac) activity
instead of PKA, WDs were cultured in the presence of Epac-speciﬁc
8-CPT-2'-O-Me-cAMP. The result was quantitatively equivalent WD
budding to that observed in the control, suggesting that the Epac
pathway is not essential to GDNF-dependent WD budding (Fig. 2).
These experiments relied on our primarymodel of eliminatingmost of
the surrounding mesodermal tissues during the WD isolation leaving
only a sheath of surrounding mesenchymal cells (Maeshima et al.,
2007; Rosines et al., 2007) in order to minimize the number of
complicating mesenchymally expressed non-budding related factors
that could overwhelmour ability to study and control the process of UB
outgrowth from the WD. WD isolated with the full surrounding
mesodermal tissue intact, which obviates the need for exogenous
ﬁbroblast growth factors allowing for budding induction with GDNF
alone, similarly displayed complete inhibition of UB outgrowth with
increased cAMP-mediated PKA activity (Supplementary Data:
Figure 1).
PKA inhibition of WD budding is PKA-2 isoform-speciﬁc
PKA can exist as either a PKA-1 or PKA-2 isozyme. These two
isoforms differ in molecular weight and sequence, and can have
contrasting phosphorylation targets, cellular localization, and tissue
distribution (Skalhegg and Tasken, 1997; Wojtal et al., 2008). Since
there currently exists no single chemical activator of protein kinase A
that has complete speciﬁcity for either form of the PKA isozymes, we
utilized pairs of cell-permeable cAMP analogues with knownfﬁan duct. Wolfﬁan ducts were isolated from E13 rat embryos and cultured for 2 days.
budded portions of the control WD. (B) PKA enzyme activity, normalized by protein
ay and divided by the slope of a phosphopeptide standard calibration curve (not shown).
as determined to be statistically signiﬁcant (*pb0.01). Green—E-cadherin; red—GFRα1;
Fig. 2. Increased PKA activity inhibited UB outgrowth from theWolfﬁan duct. Wolfﬁan ducts isolated from E13 rat embryos and cultured for 2 days. (A) The inhibitory effects of PKA
onWD budding was conﬁrmed by upstream effectors of PKA. Compared to (B) control condition using only GDNF 125 ng/mL and FGF1 125 ng/mL, adenylate cylase stimulation with
forskolin 10 μM, phosphodiesterase inhibition with IBMX 50 μM or rolipram 100 μM, and direct activation of PKA via cyclic AMP analogues 8-Br-cAMP 200 μM or (C) db-cAMP
200 μM all resulted in complete inhibition of budding in all WDs (green—E-cadherin; blue—DAPI). Epac activation by 10 μM 8CPT-2O-Me-cAMP did not inhibit budding of the WD,
ruling out the involvement of this downstream accessory pathway in cAMP-mediated budding inhibition. An increase in PKA-1 activity using a synergistic combination of 75 μM 8-
PIP-cAMP and 75 μM 8-HA-cAMPS resulted in UB outgrowth similar to that of control. Conversely, an increase in PKA-2 activity that resulted from combining 75 μM 6-MBC-cAMP
with 75 μMSp-5,6-DCl-cBIMPS resulted in total inhibition ofWD budding from all ducts. (D) PKA-2 regulatory subunits exist along the length of theWD, and are concentrated on the
luminal aspect (green—PKA-2 regulatory subunit; red—ZO-1 tight junction protein). Green arrows represent stimulation. Red lines represent inhibition. Gs=Gs-protein coupled
receptor; AC=adenylate cyclase. Numbers of buds quantiﬁed per millimeter length of n=10WDs per condition. * indicates no statistical difference compared to control. Green—E-
cadherin; blue—DAPI. Scale bar=100 μm.
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PKA isoform over the other (Schwede et al., 2000). We combined 8-
PIP-cAMP together with 8-HA-cAMPS to preferentially activate PKA-1
(reported to result in a 5:1 afﬁnity over PKA-2), and we combined 6-
MBC-cAMP and Sp-5,6-DCl-cBIMPS to preferentially activate PKA-2
(reported to result in a 60:1 afﬁnity over PKA-1). PKA-1 activation did
not cause any signiﬁcant inhibition of budding. Activation of PKA-2, in
contrast, completely arrested the budding process (Fig. 2A). Immu-
noﬂuorescent staining for the regulatory subunit of PKA-2 revealed its
existence along theWD in both theWDctrl (Fig. 2D) andWDPKA+ (data
not shown). That PKA-2 is observed in both the budded and unbudded
sections of the WD raises the possibility that while all WD cells have
some level of non-activated PKA-2 component and, as a result, the
capability of transducing the upstream cAMP signaling necessary to
limit UB formation, actual activation of PKA-2 in the unbudded region
of the WD resulting in the localized increase in PKA activity may be
mediated by upstream factors that would increase cAMP regionally.Cellular proliferation in the unbudded portions of the WDctrl and WDPKA+
are not signiﬁcantly different
To determine whether the inhibitory effects of PKA on Wolfﬁan
duct budding resulted in changes in cellular growth rate, cellular
proliferation was determined using BrdU (Fig. 3A–C). Budded and
unbudded portions were examined separately. Quantitative data from
over 20 cultures indicated a signiﬁcant difference in the rate of cellular
proliferation between the budded and unbudded portions of the
WDctrl (pb0.01), which was expected and has been previouslydemonstrated in this isolated culture system (Maeshima et al.,
2007) and in a system containing mesonephric components (Michael
and Davies, 2004). However, no statistical difference was found
between the unbudded portions of the WDctrl and WDPKA+. TUNEL
staining did not reveal a statistical difference in extent of apoptosis
between the WDPKA+ and either budded or unbudded sections of the
WDctrl (Fig. 3D–F). The observation that proliferation in theWDPKA+ is
not statistically different from the basal level of proliferation in the
unbudded portions of the WDctrl would indicate that either PKA may
be blocking budding independent of any effect on proliferation, or that
PKA may in fact be blocking the local increase in proliferation that is
expected in the budding region. Moreover, immunohistochemical
staining for ZO-1, E-cadherin, and Connexin-26 in the non-budding
PKA-activated WD revealed no effect on localization of tight,
adherens, and gap junctions respectively (Supplementary Data:
Figures 2A–C, E–G). cAMP is known to move through gap junctions
and could play a role in recruitment of cells for the budding process
(Kanaporis et al., 2008). However, blockade of gap junction
communication between cells in the WD with 18β-Glycyrrhetinic
acid similarly showed no effect in the WDPKA+ (Supplementary Data:
Figures 2D, H). This seems to argue against one potential mechanism
for suppression of WD budding—i.e. movement of cAMP to adjacent
cells via connexins.A decrease in PKA activity stimulates UB outgrowth from the WD
Thus far,wehave shown: (1) a 15-fold increase in PKA in unbudded
as opposed to budded portions of the WD; (2) activation of PKA via a
Fig. 3. Quantifying the effects of PKA activity on cell proliferation and cell death in the Wolfﬁan duct. WDs after 2 days of culture. PKA activity was increased with db-cAMP 200 μM.
(A–C) BrdU immunoﬂuorescent stain of the WDPKA+ revealed a statistically indistinguishable level of cellular proliferation from that seen in the non-budding sections of the WDctrl.
(D-F) TUNEL immunoﬂuorescent stain revealed a statistically similar extent of apoptosis in the budding and unbudded sections of the WDctrl and WDPKA+. Green—TUNEL, blue—
DAPI nuclear stain. WD perimeter indicated by dotted white lined. n=10 WDs per condition. NS—difference not signiﬁcant; * difference reached signiﬁcance (pb0.01). Scale
bar=100 μm.
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apoptosis, and markers for junctions and polarity are unaffected in
unbudded regions; and (4) the role of cAMP in this process is not
primarily mediated by diffusion through gap junctions and that this
process is reversible. The importance of PKA in the suppression of
budding would be further supported if inhibition of the pathway
promoted budding of the WD. To determine the effect of decreased
PKA activity on the WD budding event, we inhibited PKA in the WD
utilizing compounds that work either through affecting the PKA
binding sites for cAMP (with Rp-8-CPT-cAMPS 10 μM) or via PKA ATP-
site inhibitors of phosphorylation (KT5720 1–2 μM, or PKAi (14-22)
10–20 μM) (Fig. 4A–D). A marked decrease in PKA activity was
conﬁrmed in the culturedWD tissue (110 fold under control; pb0.01).
Both methods of decreasing PKA activity resulted in the robust
formation of buds from the WD that, on quantitative morphometric
analysis, featured a larger surface area (pb0.05) and represented an
increased number of formed buds per unit length of cultured WDFig. 4. PKA inactivation conversely stimulates UB outgrowth from the WD. WDs after 2 day
cAMPS 10 μM (C) KT-5720 1 μM (D) PKA inhibitor (14–22) 10 μM (E–F) Quantitative mor
inhibitor (14–22) generated a signiﬁcantly greater number of ureteric buds per standardize
control. n=10 WD cultures (*pb0.01). Scale bar=250 μm.(pb0.05) (Fig. 4E–F). Of note, PKA inhibition of theWD in the absence
of GDNF was not capable of inducing any budding (data not shown).
PKA inhibits WD budding through its effect on the duct and not
the surrounding mesenchyme
The standard isolated WD culture leaves a narrow strip of
mesenchymal cells. Communication between these mesenchymal
cells and the WD epithelium seems to be important for budding, and
these cells appear to provide paracrine factors such as activin,
neuropeptide Y, and other molecules regulating budding (Choi
et al., 2009; Iglesias et al., 2007; Maeshima et al., 2006, 2007; Rosines
et al., 2007). However, here we are interested in intracellular signaling
pathwayswithin theWD epithelium. Oneway to separate the effect of
PKA activation on WD epithelium from that on mesenchyme is to
culture the WD devoid of mesenchyme cells in a three-dimensional
Matrigel culture. Under these conditions, budding still occurs ins of culture with cell-permeable inhibitors speciﬁc for PKA: (A) control (B) Rp-8-CPT-
phometric analysis conﬁrms that the Wolfﬁan ducts cultured in the presence of PKA
d length of WD as well as signiﬁcantly greater surface area per bud, when compared to
343J.B. Tee et al. / Developmental Biology 347 (2010) 337–347response to GDNF/FGF1 (Rosines et al., 2007, 2010). Thus, to
determine whether the observed effects were a result of targeting
the adjacent mesenchymal cells or the duct itself, a collection of WDs
were stripped of attached mesenchymal cells and cultured in a
Matrigel-based suspension. PKA activation completely inhibited UB
outgrowth from these ducts, in contrast to the budding observed in
the control WD (Fig. 5). This supports the view that PKA activation
directly affects the WD epithelium rather than the adjacent MM to
inhibit UB outgrowth.Gene expression proﬁling of WD budding in the absence and
presence of PKA activation revealsmaximal effect on Ret expression
Since PKA activation did not measurably affect proliferation (in
unbudded zones), apoptosis, or markers for junctions and polariza-
tion, and because the effect of cAMP appeared to be on the epithelial
cells of the WD and not mediated by communication via gap
junctions, it was important to examine whether the transcription of
genes known to be involved in WD budding, as well as other genes,
was affected. Therefore, we measured the genetic expression of the
uncultured WD, WDctrl, and WDPKA+ structures by microarray to
determine if a rise in PKA activity in the WD was associated with
signiﬁcant changes in the expression of other genes. The over 30,000
genes measured by the microarray were ﬁrst ﬁltered to remove all
absent ﬂags from the samples. One-way ANOVA was then performed
to identify statistically signiﬁcant genes, resulting in 2,625 genes
(Fig. 6A). The list was further enriched to include only those genes
that displayed a greater than 2-fold change in expression. The
resulting set of 991 genes was then fed into Ingenuity Pathway
Analysis, a hand-curated dataset of known genetic interactions.
Ingenuity Pathway Analysis generated two networks by matching
these genes of interest which interact with other molecules in the
Ingenuity Knowledge Base and then identifying these molecules as
“network eligible molecules.” Network eligible molecules were then
utilized by the program to serve as "seeds" for generating networks
that fall under related categories of cellular interaction (Fig. 6B). The
ﬁrst network identiﬁed GDNF receptors Ret and GFRα1, linked
together with PKA, and was categorized as “Organ Morphology” and
“Cell-to-Cell Signalling and Interaction.” The second network gener-
ated by Ingenuity Pathway Analysis was categorized as “Cellular
Development,” “Connective Tissue Development and Function,” and
“Embryonic Development” and included ﬁbroblast growth factors.
In light of this developmental network support for PKA activity, and
because we were interested in growth factors and signaling events
that regulate WD budding, we further ﬁltered this set of 991 genes by
using Gene Ontology annotation GO:0007275 (Ashburner et al., 2000)
to select genes that are involved in developmental processes, resulting
in 189 genes (Fig. 6C). Ten genes within this list were annotated byFig. 5. PKA-mediated inhibition of WD budding is duct-mediated. Wolfﬁan ducts
isolated from E13 embryos with mesenchymal cells removed. These ducts were then
cultured for 3 days in a supportive 1:1 Matrigel:DMEM/F12 gel suspended in medium
in the absence (A) and presence (B) of increased PKA activity by db-cAMP 200 μM,
respectively. Green—E-cadherin adherens junction stain; blue—DAPI nuclear stain. The
inhibitory action of PKA on budding persists in this “duct-only” model indicating duct-
speciﬁc inhibition to the exclusion of mesenchymal factors (complete inhibition
observed in all n=10 cultures). Scale bar=300 μm.Gene Ontology annotation GO:0001822 as being involved in kidney
development (Table 1). Ret displayed the greatest difference in level of
normalized gene expression with a nearly 14-fold decrease in the
WDPKA+ as compared to the WDctrl. Its coreceptor GFRα1 displayed a
smaller 2.4-fold decrease in expression. The associated downregula-
tion of Ret and GFRα1 were validated by qRT-PCR. Ret, a co-receptor
for GDNF, is initially expressed throughout the WD, and becomes
limited to theUB outgrowth (Pachnis et al., 1993); it appears central to
the GDNF-dependent budding pathway in vivo and in vitro (Choi et al.,
2009;Maeshimaet al., 2006, 2007; Sainio et al., 1997; Schuchardt et al.,
1996). When the isolated WD with adjacent mesonephros was
induced to bud with GDNF, in situ hybridization revealed that
downregulation of Ret occurs along sections of the WD that are
destined to remain unbudded before signiﬁcant UB formation occurs
(Supplementary Data: Figure 3).
PKA activity regulates the GDNF–Ret dependent WD budding
pathway but not the GDNF–Ret independent “bypass” pathway for
WD budding
The observation that a signiﬁcant percentage of GDNF and Ret
knockouts develop rudimentary kidneys (Costantini and Shakya,
2006; Pichel et al., 1996) has led to the search for a GDNF–Ret
independent bypass pathway for budding. Such a pathway has been
identiﬁed in vitro (Maeshima et al., 2007) and has recently been
strongly supported by in vivo evidence (Michos et al., 2010). To
ascertain whether the role of PKA is on the GDNF–Ret dependent
pathway only or includes the bypass pathway as well, the effect of
PKA activity was compared in Ret-null WDs cultured in the standard
Ret-dependent culturemedia (containing GDNF), versus a previously-
established media condition that obviates the needs for Ret to induce
WD budding (and which does not contain GDNF) (Maeshima et al.,
2007). This latter condition bypasses the requirement for GDNF and
ensures that there is no Ret activation when used with Ret knockout
tissue. We demonstrated that an increase in PKA activity did not
suppress the outgrowth of the UB from theWD in this latter condition,
suggesting that the PKA-mediated suppression of WD budding is only
associated with Ret-dependent budding rather than affecting the Ret-
independent bypass process for in-vitro budding (Fig. 7A–D).
Stimulation of PKA activity in the non-budded WD is regulated
by BMP2
Given that activation of PKA appears to inhibit budding of the WD
via downregulation of Ret, we then sought to determinewhat possible
growth factors may stimulate the PKA pathway in the regulation of
ureteric bud formation. Members of the TGFβ family have long been
considered candidate molecules for suppression of WD budding due
to their inhibitory effect on UB and epithelial cell branching (Bush
et al., 2004; Sakurai and Nigam, 1997; Santos et al., 1993). This is
supported by in vivo data where deletion of Grem1, a BMP antagonist
that preferentially antagonizes BMP2 and BMP4 (Avsian-Kretchmer
and Hsueh, 2004), leads to renal agenesis due to failure of UB invasion
into the adjacent MM (Michos et al., 2004). BMP4 is localized to the
MM surrounding the ureteric stalk while BMP2 is expressed in the
mesenchyme adjacent to the site of UB formation (Dudley and
Robertson, 1997). This suggests that BMP2 may be involved in
limiting further UB formation around the initial UB. To determine if
BMP2 may be mediating this process, we added BMP2 (5 nM) to the
isolated WD in the presence of GDNF and FGF1, conditions which
normally lead to the formation of one or more buds. As expected,
BMP2 completely suppressed budding (Fig. 8A). We then measured
PKA activity and found it to be increased 3-fold in the BMP2 treated
WD compared to the WD treated with GDNF/FGF1 alone which
underwent budding (338 RFU/mM and 110 RFU/mM respectively;
pb0.05; Fig. 8B). This result suggests that BMP2 activation of PKA in
Fig. 6. Gene expression analysis of the effect of increased PKA activity in the Wolfﬁan duct. WDs from E13 rat embryos were cultured for 2 days. Total RNA was isolated and the
relative expression of genes was evaluated by microarray. One-way ANOVA was performed to select for statistically signiﬁcant genes. (A) Scatter plot comparing normalized
expression of this set of 2,625 genes between the WDPKA+ and WDctrl. Blue lines ﬂank a 2-fold difference in gene expression. (B) Ingenuity Pathway Analysis (IPA) of the subset of
991 genes displaying a greater than 2-fold change in expression resulted in the convergence of two networks that were generated by IPA: the ﬁrst network included hubs for Ret and
PKA and was classiﬁed as “organ morphology” and “cell-to-cell signalling and interaction” by IPA. The second network was classiﬁed as “cellular development,” “connective tissue
development and function,” and “embryonic development” that included ﬁbroblast growth factors. Red indicates upregulated genes; green highlights downregulated genes. Blue
lines highlight relationships with direct linkage to PKA; all remaining indirect relationship lines are in orange. (C) Gene Ontology identiﬁed 189 genes classiﬁed as “developmental
processes.”
344 J.B. Tee et al. / Developmental Biology 347 (2010) 337–347the WD epithelium adjacent to the emerging UB may act to delimit
further budding. When we examined the expression of BMP2 in our
model by quantitative RT-PCR at day two (budded) culture compared
to the uncultured WD, we noted a 2.1±0.3 SD-fold increased
expression of BMP2 in the unbudded sections of the WDctrl and
surrounding tissue compared with a 1.4±0.1 SD-fold decreased
expression in the budded sections (data not shown). While
expression analysis by quantitative RT-PCR revealed a Ret level that
was not signiﬁcantly different under BMP2 activation from control,signiﬁcant downregulation of GFRα1 was observed, similar to that
seen with PKA activation (Fig. 8C–D).The absence of Ret down-
regulation in theWD under BMP2 activationmay have been related to
BMP2's potential to increase Ret expression in isolation (Lo et al.,
1998), counterbalancing the downregulating effect of PKA on Ret. It
would therefore appear that the limitation of UB outgrowth seen with
BMP2 may be the result of the concurrent downregulation of GFRα1
from PKA activation. GFRα1 deﬁciency, as a coreceptor for GDNF
serving to mediate activation of the Ret tyrosine kinase receptor, can
Table 1
GO: 0001822 Kidney Development: Difference in Normalized Expression Level in
WDPKA+ compared withWDctrl. Microarray analysis by one-way ANOVA for statistically
signiﬁcant differential gene expression between WDctrl and WDPKA+. 10 genes had a 2-
fold difference in expression and were annotated as a “developmental process” in
“kidney development” by Gene Ontology and are summarized in the table. Ret
measured the greatest difference in level of normalized gene expression with a nearly
14-fold decrease in the WDPKA+ as compared to the WDctrl.
GenBank
accession #
Gene Fold
difference
Product
AJ299017 Ret −13.59 ret proto-oncogene
BE113336 Tcf21 −8.97 transcription factor 21
NM_031009 Agtr1 −3.38 angiotensin receptor 1b
NM_012774 Gpc3 −2.78 glypican 3
NM_019291 Car2 −2.64 carbonic anhydrase 2
BM389019 Fbn1 −2.23 ﬁbrillin 1
BI302830 Cd44 +2.77 CD44 antigen
BF283456 Ass1 +3.16 Arginosuccinate synthetase
NM_024400 Adamts1 +5.36 a disintegrin and metalloproteinase
with thrombospondin motifs 1
BG377337 Sall1 +5.68 spalt-like transcription factor 1
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GFRα1/ GFRα1-null mice (Cacalano et al., 1998).Fig. 8. BMP2 suppressed ureteric bud outgrowth from theWolfﬁan Duct. Wolfﬁan ducts
were isolated from E13 rat embryos and cultured for 2 days in either control media
(FGF1 and GDNF) or in the added presence 5 nM BMP. (A) BMP2 completely inhibited
UB outgrowth from the Wolfﬁan duct. Green—E-cadherin; blue—DAPI. Scale
bar=50 μm. (B) PKA enzyme activity, normalized by protein concentration assay,Discussion
During normal kidney development, a single budding event occurs
in the Wolfﬁan duct. This budding event can be initiated via a GDNF–
Ret dependent pathway (under normal circumstances) or via a
GDNF–Ret independent “bypass” pathway (under apparently unusual
circumstances when the GDNF–Ret axis is inactive). The existence of
this latter pathway is now supported by both in vitro and in vivo data
(Maeshima et al., 2007; Michos et al., 2010). This budding event
results in a “branching-competent” T-shaped structure that will
ultimately form the kidney collecting system. Considerable genetic
and in vitro data indicate that this is a limiting step in kidney
development (Maeshima et al., 2006; Michos et al., 2007; Saxen and
Sariola, 1987; Shakya et al., 2005).Fig. 7. PKA inhibited Ret-dependent ureteric bud outgrowth from the Wolfﬁan duct.WD's
fromE11micecultured for2 days.Micewereeitherheterozygous forRet (Ret(+/−)) ornull-
homozygous (Ret(−/−)). PKA activitywas increasedwith db-cAMP200 μM. (A) Control Ret
(+/−) embryos displayed WD budding in the presence of FGF1 125 ng/mL and GDNF
125 ng/mL growth factors. (B, C) Increased PKA activity in Ret(+/−) and Ret(−/−)WDs in
the presence of the same GDNF/Ret dependent growth factors FGF1 and GDNF did not show
any evidence of budding. (D) In contrast, Ret(−/−)WDs cultured in the presence of GDNF/
Ret independent growth factors FGF7 125 ng/mL and follistatin 500 ng/mL exhibited UB
outgrowth from all WDs. n=4WDs for each condition. Scale bar=100 μm.
was calculated from the slope of the linear least-squares ﬁt of the PKA assay in each
condition; the increase in PKA enzyme activity measured in those ducts exposed to
BMP2 was determined to be statistically signiﬁcant. (C) qRT-PCR conﬁrms signiﬁcant
downregulation of Ret expression in the WDPKA+ although Ret levels in the WD
exposed to BMP2 were not signiﬁcantly different from control. (D) qRT-PCR shows
signiﬁcant downregulation of GFRα expression in both the WDPKA+ and WDs cultured
with 5 nM BMP-2 in the absence of PKA inhibitor (*pb0.05 versus control; NS=not
signiﬁcant). Scale bar=100 μm.In humans and wild type rodents, the presence of more than one
WD budding event is rare, suggesting extremely tight regulation.
Nevertheless, there are unusual situations that lead to the formation
of multiple buds from the WD which can cause the formation of
multiple rudimentary kidneys. These include animals with increased
sensitivity of the WD to GDNF (Basson et al., 2005), those in which
recombinant Grem1 is added to Grem1−/− kidney rudiments
(Michos et al., 2007), and those in which one or more direct inhibitors
of WD budding are deleted (Basson et al., 2005; Bridgewater et al.,
2008; Grieshammer et al., 2004; Michos et al., 2004; Shakya et al.,
2005). Based on in vivo and/or in vitro studies, these inhibitors appear
to include members of the TGFβ superfamily including BMP2, BMP4,
and activin (Bush et al., 2004; Maeshima et al., 2006; Miyazaki et al.,
2000). These direct inhibitors of budding are all expressed in the
mesenchyme, but unlike GDNF, some are present in the epithelial WD
as well. The rapid downregulation of Grem1 seen during the onset of
metanepheric development and restriction posteriorly to the emerg-
ing UB supports the possibility that its downregulation, and the
resulting loss of attenuation of BMP signaling, may play a role in
Fig. 9. Proposed signaling process for the regulation of UB outgrowth by PKA. A possible schema for PKA-mediated regulation of budding in theWolfﬁan duct. The downregulation of
the coreceptor complex for GDNF (Ret or GFRa1) may occur by BMP alone or a BMP-mediated increase in PKA activity and leads to suppression of budding along theWD. Conversely,
a decrease in neighboring PKA activity may promote localized UB outgrowth. MM=metanephric mesenchyme; arrow indicates direction of UB outgrowth.
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et al., 2004). Our observation that PKA-2 exists to be activated in both
unbudded and budded WD cells supports the idea that the localized
activation of PKA could be the result of a regionalized and
differentiated expression of upstream factors at the nonbudding and
budding regions of the emerging UB such as BMPs. These results
suggest the possibility of both paracrine and autocrine regulation,
which is supported by in vitro data from studies using the isolatedWD
culture system (Choi et al., 2009; Maeshima et al., 2006).
We sought to uncover the potential intracellular signaling path-
ways that can be activated or deactivated in order to regulate UB
outgrowth from the WD. In cell culture models using renal epithelial
cells, PKA appears to be one of the most potent regulators of cell
migration and simple morphogenesis (Rosen et al., 1990; Santos et al.,
1993). Moreover, in IMCD cells, which are ultimately ofWD origin and
have been widely employed to model early events in renal
morphogenesis (Cantley et al., 1994; Barros et al., 1995), BMP2, a
direct and potent inhibitor of in vitro WD budding (as we have
demonstrated in this study), seems to exert its morphogenetic effect
by activating PKA (Piscione et al., 1997).
Thus, a tentative schema (Fig. 9) that emerges is that delimitation
of budding in the WD around the UB outgrowth may be tightly
regulated by balancing the activation of a bud-promoting GDNF–Ret/
GFRα1 pathway and a direct inhibitor pathway mediated by TGFβ
superfamily members (i.e. BMP2, BMP4 and activin), which in turn is
regulated by inhibitors of these direct suppressors of ureteric budding,
such as Gremlin and follistatin. While the data suggests that PKA
signaling regulates Ret/GFRα1, the limitations of this study do not
preclude the possibility that these TGFβ members may also interact
with these coreceptors for GDNF either directly or through other
undetermined pathways.
Multiple intracellular signaling pathways are likely to be involved,
but data from widely utilized cell culture models for renal morpho-
genesis suggested that PKA may be one of the key intracellular
mediators in this process, though this remained to be analyzed in the
WD itself. This led us to explore the possibility that PKA activity might
regulate the budding event. We examined the spatial patterns of PKA
activity in microdissected budded and non-budded regions of the WD
under in vitro budding conditions (GDNF and FGF1). Remarkably, we
found that PKA activity was 15 fold greater in the nonbudded region
of the WD compared to the budded region.
Given the arguments advanced above, this result suggested that
the spatial balance of PKA activity could play a role in mediating the
suppression of budding in the WD surrounding the site of initial UB
formation, while enabling budding in another region. We set out to
test this hypothesis using the isolated WD culture system and, if thehypothesis was supported, to identify a potential molecular mecha-
nism for this suppression. Fortunately, the PKA pathway is one of the
best studied signaling pathways, and very speciﬁc activators and
inhibitors of proteins in the pathway hierarchy were available that
enabled us to systematically dissect the limb of the pathway that is
key to the process being studied.
Our results indicate that PKA plays an essential role in suppressing
GDNF–Ret dependent budding but not budding by the GDNF-
independent “bypass” pathway. The PKA isoform involved is PKA-2,
and the Epac limb of the pathway does not appear to be essential for
budding. Furthermore, our results indicate that the effect might be
mediated by the suppression of cell proliferation that normally occurs
in the budding region of the WD, but is not mediated by alterations in
local apoptosis, local junction formation or cell polarization. The effect
is also not mediated through cAMP movement through gap junctions
that conceivably could have been expected to play a role in the
communication between budded and nonbudded regions of the WD.
Conversely, PKA inhibition served to increase the size and frequency
of UB formation along the WD, although this condition was incapable
of budding induction alone in the absence of GDNF.
The data suggest that the effect is mediated, at least in part, by a
striking (greater than 10 fold) suppression of Ret expression by PKA,
thereby presumably preventing GDNF action upon this region of the
WD. In fact, global microarray proﬁling for statistically signiﬁcant
gene expression indicated that, of all transcripts, Ret was the most
highly changed, further supporting a selective effect.
Our data further suggest that one or more BMPs may be important
stimulators of PKA activity which ultimately downregulates Ret and
GFRα1 in the non-budded sections of the WD. This idea is supported
by our observation that BMP2 expression increases in the nonbudding
sections of the WD and its surrounding tissue, that knockout of
Grem1, a potent BMP antagonist, results in persistent Ret expression
throughout the WD at e11.5, a time at which Ret has become
restricted to the emerging UB in normally developing kidneys
(Michos et al., 2004), and that exogenous Grem1 can result in
supernumerary UB formation (Michos et al., 2007).
In addition, the alterations in the subset of differentially-
expressed genes revealed a network of potentially interacting
genes, centered around PKA and the Ret/GFRα1 complex, some of
which may also be important in suppressing budding. While PKA-
mediated downregulation of Ret and GFRα1 expression is probably
not the only mechanism underlying the suppression of WD budding
(via paracrine and/or autocrine action of growth factors of the TGF
beta superfamily), these results provide a new level of understanding
of how WD budding might be limited around the site of initial UB
formation.
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